Scynexis Inc SEC filings SCYX
Scynexis Inc has 744 filings in SEC EDGAR's recent list, going back to Jul 10, 2002. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 25, 2026 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | May 19, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Jun 25, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | May 19, 2026 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 25, 2025 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 19, 2024 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | Jun 14, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2023 | Jun 14, 2023 |
| DEF 14A | Proxy statement | Aug 19, 2022 | Sep 28, 2022 |
| PRE 14A | Preliminary proxy statement | Aug 8, 2022 | Aug 8, 2022 |
| DEF 14A | Proxy statement | May 12, 2022 | Jun 16, 2022 |
| PRE 14A | Preliminary proxy statement | May 2, 2022 | Jun 16, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2021 | — |
| DEF 14A | Proxy statement | Apr 26, 2021 | Jun 15, 2021 |
| DEF 14A | Proxy statement | May 29, 2020 | Jul 2, 2020 |
| PRE 14A | Preliminary proxy statement | May 15, 2020 | Jul 2, 2020 |
| DEFA14A | Additional proxy material | May 7, 2019 | — |
| DEF 14A | Proxy statement | May 7, 2019 | Jun 18, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 26, 2019 | Jun 18, 2019 |
| DEFA14A | Additional proxy material | Apr 30, 2018 | — |
| DEF 14A | Proxy statement | Apr 30, 2018 | Jun 14, 2018 |
| DEFA14A | Additional proxy material | Apr 26, 2017 | — |
| DEF 14A | Proxy statement | Apr 26, 2017 | Jun 15, 2017 |
| DEFA14A | Additional proxy material | Apr 21, 2016 | — |
| DEF 14A | Proxy statement | Apr 21, 2016 | Jun 2, 2016 |
| DEFA14A | Additional proxy material | Apr 22, 2015 | — |
| DEF 14A | Proxy statement | Apr 22, 2015 | Jun 4, 2015 |
| DEFA14A | Additional proxy material | Aug 1, 2014 | — |
| DEF 14A | Proxy statement | Aug 1, 2014 | Sep 11, 2014 |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SCYX (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Jersey City, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1178253
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.